Heartflow Inc. (HTFL)
NASDAQ: HTFLHealth CareMedical/Dental InstrumentsUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
HTFL stock chart
Technical analysisKey statistics
All statistics- Market cap
- $4.10B
- P/E (TTM)
- 69.69
- EPS (TTM)
- $0.67
- Dividend yield
- None
- 52-week range
- 20.13 – 60.66
- Day range
- 43.78 – 47.16
- Volume / Avg
- 1.89M / 1.84M
- Beta
- —
- Shares outstanding
- 87.89M
52-week range
HTFL stock today
Shares of Heartflow (HTFL) finished higher on Nov 20 at $46.69, a gain of 4.62% or $2.06 per share, versus the S&P 500's 3.70% decline. At this level, HTFL sits in the middle of its 52-week range of $20.13 to $60.66: 23.0% below the high, set on Nov 11, 2026 and 131.9% above the low. HTFL is up 60.2% year to date, outperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has gained 51.3%.
At 69.7x trailing earnings, Heartflow trades above the peer-group median of 31.6x.
Summary generated from market data by MetaCap's automated system. Methodology
About Heartflow
Company profileHeartFlow, Inc., a medical technology company, provides non-invasive solutions for diagnosing and managing coronary artery diseases the United States and worldwide. Its HeartFlow Platform uses AI and computational fluid dynamics to creates a personalized 3D model of a patient's heart from a single coronary computed tomography angiography, a specialized type of scan that provides detailed images of the heart's arteries. The company provides Heartflow RoadMap Analysis that offers an intuitive anatomic visualization of the coronary arteries; Heartflow FFRCT Analysis, which calculates blood flow and pinpoints clinically; and Heartflow Plaque Analysis that provides a comprehensive assessment of coronary plaque, enabling optimized medical treatment strategies.
- Sector
- Health Care
- Industry
- Medical/Dental Instruments
- CEO
- Mr. John C.M. Farquhar
- Headquarters
- San Francisco, CA
- Employees
- 843
- IPO year
- 2025
- Website
- heartflow.com
Financial highlights
Full financialsIn fiscal 2025, Heartflow generated $176.0 million in revenue, up 39.9% from fiscal 2024, its 2nd consecutive year of revenue growth. Heartflow reported a net loss of $116.8 million, compared with a loss of $96.4 million a year earlier. Gross margin was 76.8% (up from 75.1%) and operating margin -36.4%.
| Fiscal year | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|
| Revenue | $176.03M | $125.81M | $87.17M |
| Growth | +39.92% | +44.32% | — |
| Net income | $-116.79M | $-96.43M | $-95.66M |
| EPS (diluted) | $-3.17 | $-17.98 | $-25.32 |
Analyst forecast
ForecastConsensus (9 analysts)
strong_buy
Avg. price target
$65.00+39.22%
- Strong buy 2
- Buy 6
- Hold 1
- Sell 0
- Strong sell 0
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
Earnings
Earnings history- Last reported (Sep/2026)
- Nov 12, 2026
- EPS actual vs est.
- $-0.35 vs $-0.18
- Surprise
- -94.44%
HTFL news
All HTFL news- Dodging The Heartache In HeartflowInvestor's Business Daily
- HeartFlow: 3 Key Takeaways for Long-Term InvestorsNasdaq
- HeartFlow (HTFL) Q3 2026 Earnings Call TranscriptNasdaq
- HeartFlow raises 2026 revenue outlook to $262M-$264M as Plaque nears 1,300 active accountsSeeking Alpha
- HeartFlow, Inc. Non-GAAP EPS of -$0.03 beats by $0.07, revenue of $72.86M beats by $7.66MSeeking Alpha
- Heartflow Reports Third Quarter 2026 Financial Results and Raises Full Year 2026 GuidanceGlobeNewswire
- HeartFlow Q3 2026 Earnings PreviewSeeking Alpha
- HeartFlow shares may move 17% on Nov. 12 earnings reportInvesting.com
Heartflow peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| STVNStevanato Group S.p.A. | 15.65 | -1.76% | $4.27B | vs HTFL |
| ICUIICU Medical Inc. | 172.52 | -1.84% | $4.31B | vs HTFL |
| MMEDMiniMed Group Inc. | 16.01 | -1.54% | $4.50B | vs HTFL |
| NVSTEnvista Holdings Corporation | 22.91 | -1.55% | $3.67B | vs HTFL |
| PLSEPulse Biosciences Inc | 45.55 | +2.57% | $3.35B | vs HTFL |
| IRTCiRhythm Holdings Inc. | 94.72 | +0.51% | $3.18B | vs HTFL |
| MMSIMerit Medical Systems Inc. | 84.34 | -0.08% | $5.05B | vs HTFL |
| ATRCAtriCure Inc. | 55.39 | +2.37% | $2.82B | vs HTFL |
Indexes, lists and sector
Heartflow stock FAQ
What is Heartflow's stock price today?
HTFL last traded at $46.69 as of Nov 20, 4:00 PM EST, up 4.62% on the day. Prices are delayed at least 15 minutes.
What is HTFL's P/E ratio?
HTFL trades at a trailing P/E ratio of 69.69, compared with a median of 31.6 for its closest peers.
Who is Heartflow's CEO?
Mr. John C.M. Farquhar is the chief executive officer of Heartflow Inc., which has about 843 employees.
What is the HTFL 52-week high?
The 52-week high for HTFL is $60.66 and the 52-week low is $20.13. The stock is currently 23.0% below its high.